Evidence map›Paper›PMID 31244588›Full record

ReviewTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie2019

New Approaches to Cryopreservation of Cells, Tissues, and Organs.

Michael J Taylor, Bradley P Weegman, Simona C Baicu, Sebastian E Giwa

Open access · bronzeAbstract readReview
In one paragraph

Review in Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
19.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 178 citations in OpenAlex.

  1. Article
  2. Article
  3. Cryopreservation of biological materials: applications and economic perspectives.In vitro cellular & developmental biology. Animal · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Thermodynamic Principles of Emerging Cryopreservation Technologies.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  8. Review
  9. Oocyte and Embryo Vitrification in Horses.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Investigating the effect of phase change materials on the viability of damaged tissue in disarticulated limbs.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. [Application of delayed replantation of degloving skin preserved at 4Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025
    Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael J TaylorSylvatica Biotech, Inc., North Charleston, South Carolina, USA.
Bradley P WeegmanSylvatica Biotech, Inc., North Charleston, South Carolina, USA.
Simona C BaicuSylvatica Biotech, Inc., North Charleston, South Carolina, USA.
Sebastian E GiwaSylvatica Biotech, Inc., North Charleston, South Carolina, USA.
Carnegie Mellon University · US

Funding

High Subzero Equilibrium VCA CryopreservationR44AI124835 · NIAID · SYLVATICA BIOTECH, INC. · PI TAYLOR, MICHAEL JOHN, UYGUN, KORKUT · 2018 to 2020
$1.9M
Sylvatica I-Corps Commercialization March2017- Isochoric Pressure Based Preservation of Ovarian TissueR43HD089832 · NICHD · SYLVATICA BIOTECH, INC. · PI WEEGMAN, BRADLEY P · 2016 to 2018
$275k
Nature-inspired methods for long-term banking of endocrine cells within encapsulation devicesR43DK113537 · NIDDK · SYLVATICA BIOTECH, INC. · PI PAPAS, KLEARCHOS K, TAYLOR, MICHAEL JOHN · 2017 to 2017
$224k
NIAID NIH HHS R44 AI124835NICHD NIH HHS R43 HD089832NIDDK NIH HHS R43 DK113537
6 · The paper itself

Abstract

In this concept article, we outline a variety of new approaches that have been conceived to address some of the remaining challenges for developing improved methods of biopreservation. This recognizes a true renaissance and variety of complimentary, high-potential approaches leveraging inspiration by nature, nanotechnology, the thermodynamics of pressure, and several other key fields. Development of an organ and tissue supply chain that can meet the healthcare demands of the 21st century means overcoming twin challenges of (1) having enough of these lifesaving resources and (2) having the means to store and transport them for a variety of applications. Each has distinct but overlapping logistical limitations affecting transplantation, regenerative medicine, and drug discovery, with challenges shared among major areas of biomedicine including tissue engineering, trauma care, transfusion medicine, and biomedical research. There are several approaches to biopreservation, the optimum choice of which is dictated by the nature and complexity of the tissue and the required length of storage. Short-term hypothermic storage at temperatures a few degrees above the freezing point has provided the basis for nearly all methods of preserving tissues and solid organs that, to date, have proved refractory to cryopreservation techniques successfully developed for single-cell systems. In essence, these short-term techniques have been based on designing solutions for cellular protection against the effects of warm and cold ischemia and basically rely upon the protective effects of reduced temperatures brought about by Arrhenius kinetics of chemical reactions. However, further optimization of such preservation strategies is now seen to be restricted. Long-term preservation calls for much lower temperatures and requires the tissue to withstand the rigors of heat and mass transfer during protocols designed to optimize cooling and warming in the presence of cryoprotective agents. It is now accepted that with current methods of cryopreservation, uncontrolled ice formation in structured tissues and organs at subzero temperatures is the single most critical factor that severely restricts the extent to which tissues can survive procedures involving freezing and thawing. In recent years, this major problem has been effectively circumvented in some tissues by using ice-free cryopreservation techniques based upon vitrification. Nevertheless, despite these promising advances there remain several recognized hurdles to be overcome before deep-subzero cryopreservation, either by classic freezing and thawing or by vitrification, can provide the much-needed means for biobanking complex tissues and organs for extended periods of weeks, months, or even years. In many cases, the approaches outlined here, including new underexplored paradigms of high-subzero preservation, are novel and inspired by mechanisms of freeze tolerance, or freeze avoidance, in nature. Others apply new bioengineering techniques such as nanotechnology, isochoric pressure preservation, and non-Newtonian fluids to circumvent currently intractable problems in cryopreservation.

Indexed as

CryopreservationIsochoric cryopreservationLiquidus trackingNanowarmingNon-Newtonian cryoprotectionVitrification

Identifiers

PMID31244588
PMCPMC6558330
OpenAlexW2948527349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.